Neuroprotective function of Omi to α-synuclein-induced neurotoxicity

• Main Authors: Hea-Jong Chung, Md. Saidul Islam, Md. Mashiar Rahman, Seong-Tshool Hong
• Format: Article
• Language: English
• Published: Elsevier 2020-03-01
• Series: Neurobiology of Disease
• Subjects: Omi; Oligomeric α-synuclein; α-Synuclein-induced neurotoxicity; Neurodegeneration; Parkinsonism in Drosophila
• Online Access: http://www.sciencedirect.com/science/article/pii/S096999611930381X

Astract: The main pathological hallmark of Parkinson's disease (PD) is the presence of Lewy bodies, which mainly consist of aggregated α-synuclein. Based on the neurotoxicity of oligomeric α-synuclein and its significance in the aetiology of PD, there has been decades of effort to elucidate an enzyme specifically degrading oligomeric α-synuclein. Here we report an enzyme, Omi, which specifically recognizes and precisely degrades oligomeric α-synuclein but not monomeric α-synuclein. After enzymatic and functional analyses of Omi in in vitro, we developed an in vivo assay system of dual gene interaction in Drosophila to investigate further the etiological role of Omi in PD. Pan-neuronal expression of Omi rescued Parkinsonism in a Drosophila model of PD, while Knockout of Omi exacerbated Parkinsonism. Expression of Omi counteracted the α-synuclein-induced retinal degeneration, providing additional evidence for Omi's protective role oligomeric α-synuclein. This work reports identification of the catabolic pathway of oligomeric α-synuclein as well as showing how Omi functions as the key molecule in the recognition and degradation of toxic oligomeric α-synuclein, a possible cause of neurodegeneration in PD, without affecting monomeric α-synuclein which is a native essential molecule for the normal function of neurons.